These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15520058)

  • 1. Palliative chemotherapy for advanced gastric cancer.
    Wöhrer SS; Raderer M; Hejna M
    Ann Oncol; 2004 Nov; 15(11):1585-95. PubMed ID: 15520058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for advanced gastric cancer.
    Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for advanced gastric cancer.
    Wagner AD; Unverzagt S; Grothe W; Kleber G; Grothey A; Haerting J; Fleig WE
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004064. PubMed ID: 20238327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan in the treatment of gastric cancer.
    Bugat R
    Ann Oncol; 2003; 14 Suppl 2():ii37-40. PubMed ID: 12810456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in chemotherapy for advanced gastric cancer].
    Xu RH; Teng KY
    Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
    Pozzo C; Barone C
    Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from Turkey.
    Teker F; Yilmaz B; Kemal Y; Kut E; Yucel I
    Asian Pac J Cancer Prev; 2014; 15(16):6727-32. PubMed ID: 25169516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with docetaxel in the treatment of gastric cancer.
    Philip PA
    Semin Oncol; 2005 Apr; 32(2 Suppl 4):S24-38. PubMed ID: 16015552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.
    Kim HS; Kim HJ; Kim SY; Kim TY; Lee KW; Baek SK; Kim TY; Ryu MH; Nam BH; Zang DY
    Ann Oncol; 2013 Nov; 24(11):2850-4. PubMed ID: 23942775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer. Treatment of advanced disease and new drugs.
    Caponigro F; Facchini G; Nasti G; Iaffaioli RV
    Front Biosci; 2005 Sep; 10():3122-6. PubMed ID: 15970566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.
    Brieau B; Auzolle C; Pozet A; Tougeron D; Bouché O; Soibinet P; Coriat R; Prieux C; Lecomte T; Goujon G; Marthey L; Rougier P; Bonnetain F; Ducreux M; Taieb J; Zaanan A
    Dig Liver Dis; 2016 Apr; 48(4):441-5. PubMed ID: 26775096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical development of chemotherapy for advanced gastric cancer].
    Sato A; Matsukawa M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):186-93. PubMed ID: 17283412
    [No Abstract]   [Full Text] [Related]  

  • 14. Second-line chemotherapy for advanced gastric cancer in Korea.
    Baek SK; Kim SY; Jeong JH; Cho KS; Yoon HJ
    Gastric Cancer; 2012 Oct; 15(4):345-54. PubMed ID: 22410800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in the treatment of gastric cancer in Europe.
    Köhne CH; Wils JA; Wilke HJ
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):22-5. PubMed ID: 11200144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The choice of treatment in advanced gastric cancer].
    Pozzo C; Mansueto G
    Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India.
    Babu KG; Chaudhuri T; Lakshmaiah KC; Dasappa L; Jacob LA; Babu M; Rudresha AH; Lokesh KN; Rajeev LK
    Indian J Cancer; 2017; 54(1):47-51. PubMed ID: 29199662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment of gastric cancer.
    Dickson JL; Cunningham D
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):255-63. PubMed ID: 15195888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes.
    Park SH; Choi EY; Bang SM; Cho EK; Lee JH; Shin DB; Ki Lee W; Chung M
    Anticancer Drugs; 2005 Jul; 16(6):621-5. PubMed ID: 15930889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.